Trulieve Cannabis (TRLV) stock is in focus after Georgia expanded its medical cannabis program under Senate Bill 220, allowing flower and vaporization products and broadening patient access across the state.

Trulieve Cannabis shares have been volatile around the Georgia news. The latest share price is $9.54 after a 1 day share price return that declined 2.95%. However, a 90 day share price return of 57.95% and a 1 year total shareholder return of 148.44% indicate that momentum has been strong despite a 5 year total shareholder return that declined 74.83%.

If you are looking beyond cannabis for other high growth stories, this could be a useful moment to check out 20 top founder-led companies

With Trulieve Cannabis trading at $9.54 alongside a large gap to analyst targets and an indicated intrinsic discount, the key question is whether the stock still trades below its fundamentals or if the market is already pricing in future growth.

Most Popular Narrative: 50.9% Undervalued

The most followed narrative currently places Trulieve Cannabis fair value at $19.42 compared to the last close at $9.54, framing the stock as heavily discounted and tying that view to detailed assumptions about earnings power and margins.

A strong cash position of US$353 million against US$290 million in debt and positive free cash flow of US$42 million in the quarter provide room to fund new stores, production upgrades and possible acquisitions, which can influence future revenue and earnings power.

Want to see how Trulieve Cannabis gets from current losses to that earnings profile? The narrative leans on sharper margins, leaner revenue expectations and a future earnings multiple that undercuts today’s sector average.

Result: Fair Value of $19.42 (UNDERVALUED)

However, this Trulieve Cannabis narrative still hinges on regulatory outcomes and new investments paying off, so any tax setback or weak demand could quickly challenge it.

Next Steps

Given the mixed tone around Trulieve Cannabis, this is a good moment to move quickly, look through the underlying numbers and risks yourself, and then balance that against the potential rewards highlighted in 4 key rewards and 1 important warning sign

Looking for more investment ideas beyond Trulieve Cannabis?

If Trulieve Cannabis has your attention, do not stop there. Use this moment to scan other opportunities and keep your watchlist working hard for you.

• Spot potential bargains early by checking stocks that appear mispriced using the 41 high quality undervalued stocks.
• Strengthen your portfolio's foundation by reviewing companies screened for resilient finances with the solid balance sheet and fundamentals stocks screener (47 results).
• Get ahead of the crowd by hunting for less followed opportunities through the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.